BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.4090
+0.0180 (4.60%)
At close: May 30, 2025, 4:00 PM
0.4230
+0.0140 (3.42%)
After-hours: May 30, 2025, 6:10 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $23.89 million as of May 30, 2025. Its market cap has decreased by -80.97% in one year.
Market Cap
23.89M
Enterprise Value
-7.92M
1-Year Change
-80.97%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $23.89M, a decrease of -95.86%. That is a compound annual growth rate of -51.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 23.89M | -30.35% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |